AngioDynamics
ANGO
132 hedge funds and large institutions have $1.14B invested in AngioDynamics in 2014 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 15 closing their positions.
566% more call options, than puts
Call options by funds: $2.77M | Put options by funds: $416K
246% more capital invested
Capital invested by funds: $331M → $1.14B (+$814M)
193% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 15
26% more funds holding
Funds holding: 105 → 132 (+27)
18% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 34
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$14.9M |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$6.04M |
| 3 |
HS
HighVista Strategies
Boston,
Massachusetts
|
+$4.95M |
| 4 |
Renaissance Technologies
New York
|
+$3.7M |
| 5 |
TA
Teachers Advisors
New York
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
RGM Capital
Naples,
Florida
|
-$12.6M |
| 2 |
DM
Deerfield Management
New York
|
-$9.37M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$7.71M |
| 4 |
BC
Broadfin Capital
New York
|
-$5.16M |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$4.67M |
ANGO Hedge Fund Activity: Q4 2014 in Review
132 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2014, worth a combined $1.14B — up 246% from $331M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new ANGO positions and 15 closed out — a net gain of 29 holders — while 40 added to existing stakes and 34 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $14.9M. The largest seller was RGM Capital, cutting an estimated $12.6M.
- 132 institutional investors held AngioDynamics (ANGO) as of Q4 2014, up from 105 in Q3 2014.
- Funds reported $1.14B of AngioDynamics stock for Q4 2014, up 246% quarter-over-quarter.
- 44 funds opened new AngioDynamics positions in Q4 2014 and 15 closed out, a net change of +29 holders.
- The largest AngioDynamics buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $14.9M added.
- The largest AngioDynamics seller in Q4 2014 was RGM Capital, an estimated $12.6M sold.
Based on aggregated 13F filings for Q4 2014.